{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:30Z","timestamp":1707524670229},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,9]]},"DOI":"10.7759\/cureus.31287","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T14:18:35Z","timestamp":1668003515000},"source":"Crossref","is-referenced-by-count":0,"title":["Aflibercept as Treatment for Secondary Central Serous Chorioretinopathy in a Patient With Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Estefania","family":"Ramirez Marquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo A","family":"Requejo Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariella","family":"Pappaterra-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda C","family":"Ayala Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Puebla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Nieves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando L","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftale.2018.03.011","article-title":"Acute bilateral serous central chorioretinopathy after emergency contraceptive therapy with ulipristal acetate","volume":"93","author":"Molina Mart\u00edn JC","year":"2018","unstructured":"Molina Mart\u00edn JC, Balboa Alonso M, Garc\u00eda S\u00e1nchez J, et al.. Acute bilateral serous central chorioretinopathy after emergency contraceptive therapy with ulipristal acetate. Arch la Soc Espa\u00f1ola Oftalmol. 2018, 93:347-9. 10.1016\/j.oftale.2018.03.011","journal-title":"Arch la Soc Espa\u00f1ola Oftalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen TJ","year":"2019","unstructured":"van Rijssen TJ, van Dijk EH, Yzer S, et al.. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019, 73:100770. 10.1016\/j.preteyeres.2019.07.003","journal-title":"Prog Retin Eye Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi LA","year":"1987","unstructured":"Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina. 1987, 7:111-31. 10.1097\/00006982-198700720-00009","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000477757","article-title":"Spironolactone for secondary central serous chorioretinopathy: a challenge-rechallenge case","volume":"8","author":"Kapoor KG","year":"2017","unstructured":"Kapoor KG, Sim J. Spironolactone for secondary central serous chorioretinopathy: a challenge-rechallenge case. Case Rep Ophthalmol. 2017, 8:370-4. 10.1159\/000477757","journal-title":"Case Rep Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2019.12.08","article-title":"Chorioretinal response to intravitreal aflibercept injection in acute central serous chorioretinopathy","volume":"12","author":"Jung BJ","year":"2019","unstructured":"Jung BJ, Lee K, Park JH, Lee JH. Chorioretinal response to intravitreal aflibercept injection in acute central serous chorioretinopathy. Int J Ophthalmol. 2019, 12:1865-71. 10.18240\/ijo.2019.12.08","journal-title":"Int J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31825dd281","article-title":"Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis","volume":"32","author":"Kurup SK","year":"2012","unstructured":"Kurup SK, Oliver A, Emanuelli A, Hau V, Callanan D. Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis. Retina. 2012, 32:2096-101. 10.1097\/IAE.0b013e31825dd281","journal-title":"Retina"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150480005","article-title":"The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy","volume":"115","author":"Yannuzzi LA","year":"1997","unstructured":"Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol. 1997, 115:478-85. 10.1001\/archopht.1997.01100150480005","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00173-6","article-title":"Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy","volume":"107","author":"Yannuzzi LA","year":"2000","unstructured":"Yannuzzi LA, Freund KB, Goldbaum M, et al.. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology. 2000, 107:767-77. 10.1016\/S0161-6420(99)00173-6","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.10.012","article-title":"Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization","volume":"141","author":"Tong JP","year":"2006","unstructured":"Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol. 2006, 141:456-62. 10.1016\/j.ajo.2005.10.012","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2040622312446007","article-title":"Aflibercept in wet age-related macular degeneration: a perspective review","volume":"3","author":"Ohr M","year":"2012","unstructured":"Ohr M, Kaiser PK. Aflibercept in wet age-related macular degeneration: a perspective review. Ther Adv Chronic Dis. 2012, 3:153-61. 10.1177\/2040622312446007","journal-title":"Ther Adv Chronic Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101289","article-title":"Intraocular inflammation secondary to intravitreal brolucizumab treated successfully with Sub-Tenon triamcinolone: a case report","volume":"25","author":"Kurup SK","year":"2022","unstructured":"Kurup SK, Tabbaa T, Echegaray JJ, Oliver AL. Intraocular inflammation secondary to intravitreal brolucizumab treated successfully with Sub-Tenon triamcinolone: a case report. Am J Ophthalmol Case Rep. 2022, 25:101289. 10.1016\/j.ajoc.2022.101289","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2014.00082","article-title":"Treatment of amblyopia in the adult: insights from a new rodent model of visual perceptual learning","volume":"8","author":"Bonaccorsi J","year":"2014","unstructured":"Bonaccorsi J, Berardi N, Sale A. Treatment of amblyopia in the adult: insights from a new rodent model of visual perceptual learning. Front Neural Circuits. 2014, 8:82. 10.3389\/fncir.2014.00082","journal-title":"Front Neural Circuits"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/09273972.2011.600420","article-title":"Can human amblyopia be treated in adulthood?","volume":"19","author":"Astle AT","year":"2011","unstructured":"Astle AT, McGraw PV, Webb BS. Can human amblyopia be treated in adulthood?. Strabismus. 2011, 19:99-109. 10.3109\/09273972.2011.600420","journal-title":"Strabismus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000293","article-title":"Amblyopia update: new treatments","volume":"27","author":"Vagge A","year":"2016","unstructured":"Vagge A, Nelson LB. Amblyopia update: new treatments. Curr Opin Ophthalmol. 2016, 27:380-6. 10.1097\/ICU.0000000000000293","journal-title":"Curr Opin Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_11_19","article-title":"Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: a review","volume":"67","author":"Gopal SK","year":"2019","unstructured":"Gopal SK, Kelkar J, Kelkar A, Pandit A. Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: a review. Indian J Ophthalmol. 2019, 67:1392-9. 10.4103\/ijo.IJO_11_19","journal-title":"Indian J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13585","article-title":"Treating amblyopia in adults with prosthetic occluding contact lenses","volume":"96","author":"Garcia-Romo E","year":"2018","unstructured":"Garcia-Romo E, Perez-Rico C, Rold\u00e1n-D\u00edaz I, Ar\u00e9valo-Serrano J, Blanco R. Treating amblyopia in adults with prosthetic occluding contact lenses. Acta Ophthalmol. 2018, 96:e347-54. 10.1111\/aos.13585","journal-title":"Acta Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120255-aflibercept-as-treatment-for-secondary-central-serous-chorioretinopathy-in-a-patient-with-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:52Z","timestamp":1707507652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120255-aflibercept-as-treatment-for-secondary-central-serous-chorioretinopathy-in-a-patient-with-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.31287","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}